Cellstation High Throughput Bioreactors

The Fluorometrix family of Cellstation™ High Throughput Bioreactors is a paradigm shifting cell cultivation technology. It allows for highly parallel bioprocessing by a multiple-vessel architecture with non-invasive monitoring and control of critical process parameters. The core technology is derived from a common patent base licensed from the University of Maryland, Baltimore County (UMBC) under extended terms of exclusivity. Key advantages are deployment of pre-calibrated, disposable bioreactors that confer enormous time and labor advantages over traditional technology. This cost saving, scaleable, automated culture technology is well positioned to facilitate the entire biopharma cell culturing and fermentation process and will not only save millions in labor and materials, but will also reduce the time to market for new drugs - an additional incalculable savings in opportunity cost and human life. Fluorometrix's technology provides the missing link to fully deliver on the promise of post-genomics and proteome based drug development.